IMMUNICOM, INC.
Healing reimagined through Immunopheresis®
San Diego, United States · Founded 2022
- Headquarters
- San Diego, California
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- immunicom.com
About
Immunicom is a privately-held immuno-oncology company developing Immunopheresis®, a breakthrough subtractive device-based therapy that works outside the body to remove immune barriers from the blood. The technology is designed to treat cancer, inflammatory, renal, and autoimmune diseases with fewer side effects than conventional treatments. Worldwide clinical trials are underway across multiple cancer types.
Summary
IMMUNICOM, INC. is a Biotech company based in San Diego, United States, founded in 2022.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immunicom-inc"><img src="https://indexed.vc/api/badge/company/immunicom-inc" alt="IMMUNICOM, INC. on Indexed.vc" width="260" height="76" /></a>